NSE: CONCORD • Promoter, FII, DII Holdings for Tickjournal
Promoter Holding54.39%
FII Holding0.00%
DII Holding0.00%
Public Holding44.95%
Total Shareholders4,718
As ofSept 2025
View the latest shareholding pattern of Concord Drugs (CONCORD) including promoter, FII, DII, and public holdings.
Track CONCORD ownership changes over time and document your investment thesis in Tickjournal — your personal trade journal.
(See CONCORD quarterly performance)
Concord Drugs (CONCORD) Shareholding Summary
Promoter holding remains unchanged at 54.39% in Sept 2025
FII/FPI holding remains unchanged at 0.00% in Sept 2025
DII holding remains unchanged at 0.00% in Sept 2025
Public holding has increased from 42.57% to 44.95% in Sept 2025
Number of shareholders decreased from 5,189 to 4,718 in Sept 2025
CONCORD Quarterly Ownership Changes
Quarter-over-quarter changes for Concord Drugs from Jun 2025 to Sept 2025.
Concord Drugs shareholding pattern reveals who owns CONCORD stock and how ownership changes over time. High promoter stakes in CONCORD often signal management confidence, while rising FII/DII holdings suggest growing institutional interest. Use Tickjournal to log these insights alongside your CONCORD trades. Concord Drugs stock price data download
Combine CONCORD ownership analysis with price movements and financial performance for a complete investment picture. (See CONCORD DCF)